middl
east
respiratori
syndrom
coronaviru
merscov
beta
coronaviru
caus
sever
lethal
acut
respiratori
diseas
human
remark
differ
human
coronavirus
includ
known
caus
mild
respiratori
infect
may
world
health
organ
receiv
laboratoryconfirm
case
countri
merscov
identifi
case
includ
death
relat
merscov
infect
case
fatal
rate
may
mer
outbreak
south
korea
largest
outbreak
outsid
middl
east
caus
death
case
singl
infect
person
outbreak
rais
concern
potenti
global
merscov
pandem
howev
current
licens
therapeut
drug
prophylact
vaccin
avail
protect
merscov
vaccin
best
way
control
prevent
infecti
diseas
sinc
merscov
respiratori
pathogen
merscov
vaccin
induc
antigenspecif
secretori
iga
siga
antibodi
mucos
surfac
probabl
effect
prevent
merscov
replic
site
viru
infect
mode
merscov
transmiss
clearli
understood
one
studi
proven
human
intestin
tract
may
new
transmiss
rout
merscov
indic
antigenspecif
siga
antibodi
gastrointestin
mucosa
consider
indic
therefor
urgent
need
develop
effect
mucos
immun
vaccin
merscov
especi
induc
gastrointestin
mucos
immun
date
research
develop
number
promis
approach
merscov
vaccin
candid
includ
dna
vaccin
recombin
viral
vector
proteinbas
platform
howev
vaccin
enter
clinic
trial
except
dna
vaccin
complet
phase
clinic
trial
differ
merscov
vaccin
approach
advantag
disadvantag
immunogen
eas
mass
product
preexist
immun
addit
potenti
advers
effect
factor
must
taken
account
balanc
creat
success
vaccin
use
human
andor
anim
subunit
vaccin
consist
major
pathogen
antigen
fragment
possess
mani
advantag
minim
side
effect
high
safeti
profil
high
yield
studi
shown
receptorbind
domain
rbd
merscov
spike
protein
major
antigen
determin
induct
neutral
antibodi
essenti
target
mer
subunit
vaccin
meanwhil
previou
studi
identifi
stabl
neutral
viral
rbd
fragment
five
follow
known
version
therefor
merscov
protein
potenti
use
design
effect
vaccin
mucos
vaccin
subunit
vaccin
requir
antigen
deliveri
vector
adjuv
optim
immun
respons
display
heterolog
pathogen
protein
surfac
bacteria
ration
way
enhanc
immunogen
vaccin
novel
surfac
display
system
contain
nonliv
genet
unmodifi
gramposit
enhanc
matrix
gem
particl
protein
anchor
pa
lactococcu
lacti
peptidoglycan
hydrolas
acma
gempa
surfac
display
system
gempa
surfac
display
system
flexibl
effect
inexpens
easytohandl
altern
heterolog
protein
peptid
gem
particl
system
appli
parasit
oral
vaccin
streptococcu
pneumonia
mucos
vaccin
porcin
circoviru
type
vaccin
among
other
pa
system
surfac
display
lysin
motif
lysm
deriv
ctermin
peptidoglycanbind
domain
acma
autolysin
lactococcu
lacti
bind
gem
particl
noncoval
manner
number
lysm
protein
affect
effici
foreign
protein
bind
gem
studi
show
three
lysm
domain
fusion
protein
optim
peptidoglycanbind
activ
biolog
function
previou
studi
shown
two
lysm
domain
fusion
protein
much
stronger
bind
activ
other
therefor
studi
number
lysm
protein
necessari
lysm
domain
often
part
domain
linker
sequenc
convey
lysm
domain
mobil
flexibl
fuse
target
protein
allow
protein
attain
optim
orient
bind
cell
wall
howev
linker
peptid
pa
antigen
protein
yet
explor
influenc
bind
affin
immunogen
fusion
protein
consid
number
lysm
linker
sequenc
fusion
protein
may
influenc
pa
bind
efficaci
gem
particl
immunogen
antigen
protein
express
base
recombin
baculoviru
express
system
fusion
protein
test
abil
bind
gem
particl
immunogen
antigen
protein
test
mucos
immun
system
immun
respons
caus
merscov
blp
candid
vaccin
also
detect
intranas
immun
mous
model
without
adjuv
construct
follow
merscov
rbd
gene
encod
glycoprotein
residu
amplifi
pcr
use
codonoptim
genbank
templat
oligonucleotid
primer
rbdf
linkerrbdr
tabl
gene
encod
two
lysm
amplifi
pcr
use
codonoptim
l
lacti
templat
oligonucleotid
primer
pcr
fragment
amplifi
second
pcr
use
last
product
rbd
gene
templat
oligonucleotid
primer
rbdf
result
construct
digest
xbai
kpni
insert
plasmid
invitrogen
carlsbad
ca
usa
gener
recombin
plasmid
construct
recombin
gene
gene
amplifi
pcr
insert
plasmid
xbai
kpni
digest
gener
recombin
plasmid
respect
separ
transform
e
coli
cell
gener
recombin
bacmid
recombin
bacmid
transfect
spodoptera
frugiperda
gibco
grand
island
ny
usa
insect
cell
use
liposom
accord
bactobac
express
system
manual
invitrogen
usa
cultur
plate
cellsml
gener
recombin
baculovirus
supernat
contain
recombin
baculoviru
harvest
day
transfect
viral
stock
ifa
perform
confirm
express
previous
describ
briefli
cell
cultur
plate
cellsml
infect
recombin
baculoviru
h
infect
cultur
plate
fix
cold
aceton
overnight
wash
three
time
tween
pbst
incub
rabbit
antimerss
polyclon
antibodi
sino
biolog
inc
beij
china
contain
bovin
serum
albumin
bsa
sigmaaldrich
usa
h
three
wash
pbst
fitclabel
goat
rabbit
igg
antibodi
bioworld
inc
st
loui
mn
usa
ad
evan
blue
sigmaaldrich
st
loui
mn
usa
h
wash
cell
observ
fluoresc
microscop
western
blot
analysi
cultur
cell
infect
recombin
baculoviru
rbv
rbv
centrifug
g
min
cultur
supernat
obtain
supernat
fraction
cell
pellet
wash
three
time
mm
pb
ph
resuspend
pb
sampl
supernat
fraction
cell
pellet
transfer
onto
polyvinyliden
fluorid
pvdf
membran
merck
millipor
billerica
usa
sdspage
denatur
condit
western
blot
rabbit
antimerscov
polyclon
antibodi
gem
particl
prepar
describ
detail
elsewher
brief
cell
l
lacti
strain
harvest
wash
pb
boil
trichloroacet
acid
min
gener
socal
gem
particl
count
chamber
number
gem
particl
per
millilit
count
one
unit
u
defin
gem
particl
standard
procedur
follow
one
unit
gem
particl
ad
ml
recombin
baculoviru
cultur
supernat
cultur
slowli
mix
rotari
shaker
room
temperatur
min
gener
bind
gem
particl
concentr
g
min
wash
resuspend
steril
pb
store
concentr
use
sdspage
western
blot
analys
bind
gem
particl
complex
resuspend
sdspage
sampl
buffer
beyotim
biotechnolog
shanghai
china
separ
sdspage
transfer
electroblot
onto
pvdf
transfer
membran
denatur
condit
western
blot
rabbit
antimerscov
polyclon
antibodi
ifa
bind
gem
particl
concentr
g
min
resuspend
bsa
block
min
bind
gem
particl
incub
dilut
rabbit
antimerscov
polyclon
antibodi
pb
bsa
min
three
wash
complex
incub
fitclabel
goat
antirabbit
igg
antibodi
h
view
photograph
use
zeiss
microscop
incid
uv
illumin
zeiss
axiovis
digit
imag
system
zeiss
oberkochen
germani
maximum
bind
capac
fusion
protein
bind
gem
particl
u
gem
particl
incub
min
room
temperatur
ml
recombin
baculoviru
cultur
supernat
sdspage
use
analyz
fusion
protein
bind
gem
particl
gel
imag
system
analysi
softwar
version
tanon
shanghai
china
meanwhil
amount
fusion
protein
bind
gem
particl
determin
densitometr
analysi
scan
coomassi
brilliant
bluestain
polyacrylamid
paa
gel
quantiti
one
imag
analysi
softwar
version
calibr
curv
gener
use
bsa
protein
standard
paa
gel
total
two
batch
balbc
mice
week
old
femal
procur
changchun
yisi
laboratori
anim
technolog
co
ltd
changchun
china
immun
batch
twenti
mice
randomli
distribut
four
group
n
per
group
vaccin
intramuscularli
im
mice
group
vaccin
pb
control
mice
group
vaccin
gem
adjuv
complex
seppic
pari
franc
polyi
c
sigma
st
loui
mn
usa
control
mice
group
vaccin
antigen
protein
adjuv
group
mice
group
vaccin
antigen
protein
adjuv
group
group
boost
twice
interv
blood
sampl
collect
two
five
eight
week
postimmun
wpi
batch
ii
thirti
mice
random
three
group
vaccin
intranas
mice
group
vaccin
pb
control
mice
group
vaccin
antigen
protein
mice
group
vaccin
antigen
protein
mix
adjuv
seppic
pari
franc
group
boost
twice
interv
blood
sampl
collect
two
five
eight
week
wpi
serum
sampl
inactiv
min
prior
analysi
lung
lavag
sampl
collect
ml
cold
pb
gutwash
sampl
collect
ml
cold
pb
ice
eight
wpi
sera
lung
lavag
gutwash
sampl
supernat
collect
centrifug
g
min
store
use
pseudotyp
viru
neutral
assay
perform
describ
previous
brief
merspseudotyp
viru
mix
equal
volum
serial
dilut
mous
sera
mixtur
incub
min
incub
huh
cell
h
sampl
assay
quadrupl
incomplet
medium
replac
complet
dmem
fetal
bovin
penicillinstreptomycin
sampl
incub
h
luciferas
activ
sampl
measur
infinit
micropl
spectrophotomet
tecan
switzerland
lung
lavag
gutwash
sera
sampl
anim
collect
eight
wpi
test
rbdspecif
iga
igg
antibodi
elisa
briefli
purifi
rbd
antigen
produc
ecoli
carbon
buffer
use
coat
microtit
plate
corningcostar
corn
ny
usa
overnight
follow
three
wash
pbst
block
pbst
contain
bsa
h
plate
incub
serial
dilut
sampl
pb
contain
wv
bsa
h
three
wash
cycl
pbst
plate
incub
follow
hrplabel
goat
antibodi
antimous
iga
southernbiotech
birmingham
al
usa
antimous
igg
bioworld
st
loui
mn
usa
antimous
southern
biotech
usa
antimous
southernbiotech
birmingham
al
usa
h
subsequ
plate
wash
three
time
tetramethylbenzidin
substrat
ad
per
well
color
develop
stop
ad
optic
densiti
valu
measur
nm
use
elisa
plate
reader
biorad
hercul
ca
usa
elispot
cytokin
assay
perform
describ
previous
splenocyt
harvest
complet
rpmi
medium
day
third
immun
plate
elispot
plate
mabtech
nacka
sweden
purifi
rbd
antigen
produc
ecoli
ad
well
final
concentr
stimul
cytokin
product
incub
h
detect
use
mous
enzymelink
immunospot
elispot
kit
accord
manufactur
instruct
spotform
cell
sfc
count
elispot
reader
multispotread
spectrum
aid
strasberg
germani
splenocyt
prolifer
assay
perform
describ
brief
splenocyt
stimul
without
purifi
rbd
antigen
produc
ecoli
concentr
cellsml
triplic
plate
incub
h
solut
keygen
biotech
nanj
china
ad
well
incub
addit
h
plate
measur
nm
use
infinit
micropl
spectrophotomet
formula
prolifer
index
pi
express
follow
pi
od
stimul
cultur
od
nonstimul
cultur
od
nonstimul
cultur
od
control
cultur
frequenc
activ
b
cell
cell
splenocyt
evalu
flow
cytometri
splenocyt
cultur
complet
rpmi
stimul
rbd
antigen
produc
ecoli
h
cell
stain
follow
antimous
antibodi
bd
bioscienc
san
jose
ca
usa
wash
label
cell
sampl
examin
facsariatm
cell
sorter
bd
bioscienc
san
jose
ca
usa
splenocyt
harvest
day
third
immun
stimul
rbd
antigen
produc
ecoli
h
supernat
collect
centrifug
g
min
helper
cytokin
tumor
necrosi
factor
tnf
interferon
ifn
interleukin
il
cytokin
supernat
detect
use
mous
elisa
cytokin
kit
mabtech
nacka
sweden
accord
manufactur
instruct
purifi
rbd
antigen
test
produc
similar
background
respons
pb
gem
immun
anim
result
express
mean
sd
figur
gener
use
graphpad
prism
softwar
graphpad
softwar
inc
signific
differ
group
analyz
use
oneway
anova
deem
signific
p
valu
less
treatment
mice
accord
welfar
ethic
guidanc
chines
laboratori
anim
gb
agreement
approv
anim
welfar
ethic
committe
institut
veterinari
medicin
militari
academi
scienc
laboratori
anim
care
use
committe
author
permit
number
strategi
design
fusion
protein
shown
figur
b
rbd
fuse
without
linker
ifa
result
show
compar
control
cell
cell
express
protein
emit
strong
green
fluoresc
signal
antimerss
polyclon
antibodi
rbd
suggest
express
fusion
protein
good
antigen
figur
furthermor
western
blot
analysi
show
recombin
protein
success
express
solubl
protein
secret
supernat
figur
surfac
locat
fusion
protein
gem
particl
analyz
sdspage
figur
western
blot
figur
ifa
antimerss
polyclon
antibodi
figur
sdspage
western
blot
observ
show
fusion
protein
bound
gem
particl
meanwhil
immunofluoresc
microscopi
observ
show
compar
gem
particl
neg
control
combin
gem
particl
fusion
protein
emit
strong
green
fluoresc
therefor
result
indic
fusion
protein
anchor
gem
particl
investig
whether
differ
bind
activ
gem
particl
caus
differ
lysm
repeat
extens
anchor
protein
plu
linker
rbd
direct
bind
capac
studi
gem
particl
perform
sdspage
figur
analyz
maximum
bind
capac
fusion
protein
bind
gem
particl
u
gem
particl
combin
ml
recombin
baculoviru
cultur
supernat
accord
rel
bind
quantiti
coomassi
brilliant
bluestain
polyacrylamid
gel
increas
bind
cultur
supernat
volum
u
gem
particl
rel
quantiti
bind
fusion
protein
increas
rel
quantiti
fusion
protein
ml
ml
volum
similar
result
suggest
gem
particl
bind
fusion
protein
satur
furthermor
estim
gem
particl
bind
fusion
protein
fusion
protein
fusion
protein
quantiti
one
imag
analysi
softwar
result
indic
bind
activ
better
thu
select
experi
mice
antibodi
respons
serum
merscov
measur
pseudotyp
viru
neutral
assay
shown
endpoint
dilut
titer
two
five
eight
wpi
enhanc
immun
respons
mice
appli
complex
polyi
c
adjuv
screen
mice
intramuscular
administr
laboratori
result
show
antibodi
level
sera
mice
gradual
increas
plateau
eight
week
signific
differ
neutral
activ
two
group
two
five
week
figur
result
suggest
immunogen
stronger
thu
select
intranas
vaccin
experi
mice
analyz
whether
intranas
mice
could
produc
system
humor
immun
respons
specif
serum
antibodi
level
determin
pseudotyp
viru
neutral
assay
elisa
commerci
adjuv
base
polym
technolog
alreadi
appli
adjuv
veterinari
vaccin
field
use
parenter
mucos
immun
decid
whether
could
enhanc
immun
respons
mice
intranas
immun
mice
pseudotyp
viru
neutral
assay
data
show
plu
induc
strong
neutral
merscov
infect
latter
display
much
higher
neutral
titer
former
figur
similar
phenomenon
also
found
rbdspecif
igg
figur
figur
figur
antibodi
sera
eight
wpi
caus
plu
meanwhil
ratio
plu
much
higher
figur
suggest
could
induc
immun
respons
collect
data
show
could
induc
system
immun
respons
adjuv
could
significantli
enhanc
antibodi
respons
verifi
whether
could
produc
local
immun
respons
intranas
immun
mice
specif
iga
level
lung
lavag
fluid
intestin
wash
determin
elisa
eight
wpi
data
show
mucos
iga
level
present
among
tissu
organ
plu
group
iga
level
obviou
plu
group
figur
result
show
mucos
immun
respons
induc
candid
vaccin
effect
significantli
increas
adjuv
analyz
effect
splenocyt
prolif
respons
ex
vivo
splenocyt
prolifer
assay
perform
stimul
rbd
protein
splenocyt
harvest
mice
intranas
immun
plu
prolifer
effici
mice
immun
without
figur
therefor
data
suggest
could
evok
potent
antigenspecif
immun
respons
activ
marker
effector
immun
cell
therefor
detect
frequenc
splenocyt
collect
immun
mice
flow
cytometri
analyz
activ
b
cell
cell
cell
express
b
cell
figur
cell
figur
cell
figur
mice
immun
significantli
increas
compar
express
cell
mice
immun
result
suggest
induc
potent
immun
activ
import
initi
whole
immun
respons
sinc
analyz
whether
display
better
efficaci
splenocyt
prolif
respons
splenocyt
activ
ex
vivo
restimul
splenocyt
next
detect
whether
could
also
promot
cytokin
secret
profil
immun
mice
splenocyt
collect
immun
mice
ex
vivo
restimul
rbd
ifnr
tnfa
cytokin
supernat
detect
elisa
level
cytokin
group
significantli
higher
group
figur
elispot
assay
show
amount
splenocyt
secret
ifnr
also
remark
increas
group
similar
result
elisa
overal
data
show
induc
secret
cytokin
suggest
stronger
immun
respons
merscov
caus
human
respiratori
infect
high
mortal
rate
humantohuman
transmiss
develop
effect
merscov
vaccin
especi
subunitbas
vaccin
provid
safest
way
prevent
continu
dissemin
merscov
human
camel
previou
result
show
merscov
rbdbase
subunit
vaccin
display
effect
immunogen
merscov
challeng
mice
studi
shown
recombin
rbd
merscov
spike
protein
intranas
vaccin
induc
robust
local
mucos
immun
respons
lung
stronger
system
cellular
immun
respons
subcutan
vaccin
mice
demonstr
intranas
rbdbase
subunit
vaccin
safe
effect
mean
prevent
merscov
infect
studi
demonstr
merscov
could
replic
robustli
human
primari
intestin
epitheli
cell
intestin
organoid
small
intestin
explant
could
resist
fedstat
gastrointestin
fluid
caus
enter
merscov
infect
therefor
extrem
import
merscov
vaccin
induc
respiratori
gastrointestin
mucos
immun
studi
develop
rbdbase
merscov
subunit
vaccin
novel
bacteri
antigen
display
system
evalu
immunogen
specif
mucos
immun
lung
intestin
mucosa
system
immun
respons
due
immun
via
intranas
rout
novel
method
surfac
display
antigen
base
nonrecombin
nonliv
lactococcu
lacti
bacteriaassign
gem
particl
lactococcu
lacti
long
histori
use
food
recogn
safe
particl
boil
acid
mainli
consist
bacterialshap
peptidoglycan
sphere
lack
cell
wall
compon
intracellular
materi
recogn
especi
safe
particl
bind
exogen
antigen
pa
high
affin
high
load
capac
addit
advantag
particl
bind
chimer
anchor
fusion
protein
cultur
medium
room
temperatur
effici
strong
select
manner
particl
need
onestep
centrifug
process
obtain
purifi
fusion
protein
without
extra
purif
step
easier
obtain
purifi
antigen
bacteriumlik
particl
vaccin
compar
viruslik
particl
vaccin
gempa
system
appli
varieti
anim
model
shown
strong
antigenspecif
system
immun
respons
parenter
vaccin
robust
local
system
respons
induc
mucos
vaccin
system
even
proven
protect
specif
pathogen
includ
parasit
bacteria
virus
result
show
merscov
rbd
protein
success
display
surfac
gem
particl
gempa
system
gempa
system
pa
lysm
ctermin
peptidoglycanbind
domain
acma
autolysin
lactococcu
lacti
bind
gem
particl
noncoval
manner
one
import
factor
determin
bind
activ
fusion
protein
number
lysm
wild
number
lysm
domain
protein
differ
greatli
current
studi
optim
number
lysm
domain
gempa
system
proper
function
differ
differ
group
possibl
reason
fusion
protein
fuse
differ
target
protein
result
show
bind
activ
remark
higher
gem
particl
consist
result
kenji
okano
anton
steen
lysm
domain
often
separ
domain
linker
sequenc
rais
specul
lysm
domain
mobil
flexibl
fuse
target
protein
allow
protein
attain
optim
orient
bind
cell
wall
result
show
bind
activ
slightli
higher
furthermor
signific
differ
neutral
activ
among
sera
mice
intramuscularli
immun
result
clearli
suggest
linker
peptid
pa
rbd
protein
could
increas
bind
capac
pa
immunogen
rbd
fusion
protein
consist
result
linker
recombin
fusion
protein
could
improv
biolog
activ
function
domain
thu
studi
repres
signific
advanc
develop
gempa
system
merscov
transmiss
camel
human
via
respiratori
droplet
saliva
direct
contact
infect
camel
consumpt
contamin
camel
milk
meat
effect
merscov
vaccin
provid
protect
invas
merscov
blood
also
provid
protect
invas
infect
respiratori
tract
gastrointestin
tract
therefor
develop
merscov
altern
vaccin
mucos
immun
respons
necessari
studi
demonstr
promis
candid
intranas
immun
merscov
subunit
vaccin
moreov
use
adjuv
intranas
vaccin
polym
sodium
polyacrylatebas
adjuv
enhanc
protect
effect
live
vaccin
mucos
immun
result
show
plp
induc
strong
neutral
merscov
pseudotyp
viru
infect
rbdspecif
igg
antibodi
respons
sera
respons
also
significantli
increas
presenc
adjuv
effect
activ
immun
cell
ratio
indic
polar
moreov
ratio
igg
induc
blp
plu
higher
blp
alon
suggest
show
adjuvant
induc
immun
respons
siga
antibodi
may
limit
merscov
replic
mucos
surfac
data
show
intranas
immun
blp
could
induc
mucos
siga
especi
small
intestin
confirm
blp
vaccin
could
induc
strong
local
mucos
immun
via
intranas
rout
knowledg
first
report
show
success
gener
siga
small
intestin
among
publish
merscov
vaccin
candid
furthermor
evalu
splenocyt
ex
vivo
restimul
detect
splenocyt
prolifer
splenocyt
activ
cytokin
secret
result
show
blp
vaccin
could
increas
splenocyt
prolifer
earli
marker
activ
immun
cell
observ
b
cell
cell
cell
immun
mous
splenocyt
activ
rapidli
mock
mice
restimul
antigen
next
splenocyt
supernat
detect
elisa
andor
elispot
level
blp
vaccin
presenc
adjuv
higher
blp
vaccin
alon
taken
togeth
blp
adjuv
strongli
induc
system
local
mucos
immun
may
sodium
polyacryl
mainli
compon
adjuv
promot
retent
antigen
sustain
releas
antigen
nasal
mucosa
addit
adjuv
recruit
immun
cell
nasal
mucosa
inflammatori
respons
summari
construct
merscov
bacteriumlik
particl
vaccin
display
rbd
antigen
protein
studi
result
clearli
demonstr
vaccin
induc
strong
specif
mucos
immun
lung
intestin
tract
system
immun
respons
adjuv
via
intranas
rout
merscov
bacteriumlik
particl
promis
candid
vaccin
protect
efficaci
evalu
vaccin
anim
model
consid
futur
studi
